Investor relations

Listed on NASDAQ since 1991 and a member of the S&P 500®, IDEXX Laboratories, Inc. (IDXX) is a global leader in veterinary diagnostics, software, and water microbiology testing.

Listen: 2023 investor day

Q2 2023 Results — August 1

Corporate Responsibility Report

Corporate Responsibility is fundamental to how IDEXX operates as a business, employer, supplier, customer, and member of the community.

Read our 2022 report

Investor resources

Upcoming earnings dates

Q3 2023: November 1

Investor resources

Investor Relations
One IDEXX Drive
Westbrook, Maine 04092

1-207-556-8155 or 1-800-548-6733
Fax: 1-207-556-4427

Latest news

IDEXX Announces Second Quarter Results

Q2 2023 Earnings Snapshot

IDEXX Releases 2022 Corporate Responsibility Report, Providing Environmental, Social, and Governance Updates
Read more

IDEXX Elects Irene Chang Britt to Board of Directors
Read more

IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry’s Most Comprehensive Renal Testing Portfolio
​​​​​​​Read more

IDEXX to Present at Stifel Conference and Announces 2023 Investor Day
​​​​​​​Read more

IDEXX Announces First Quarter Results

Q1 2023 Earnings Snapshot

IDEXX to Present at Two Upcoming Institutional Investor Conferences
Read more

Groundbreaking IDEXX Study Reveals Opportunities to Increase Veterinary Practice Productivity
​​​​​​​Read more

IDEXX Announces Fourth Quarter and Full Year 2022 Results

Q4 2022 Earnings Snapshot

IDEXX to Release 2022 Fourth Quarter and Full Year Financial Results
​​​​​​​Read more

Deeper Clinical Insights from IDEXX Preventive Care Offerings Help Veterinarians Detect Issues Sooner So Pets Can Live Their Best Lives
​​​​​​​Read more

IDEXX Laboratories to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
Read more

IDEXX Laboratories Announces Third Quarter Results

IDEXX Announces Second Quarter Results

IDEXX Announces New Goals in Its 2021 Corporate Responsibility Report and Advances Progress on Environmental, Social, and Governance Initiatives
Read more

IDEXX Empowers Veterinarians with New Testing Insights that Support Earlier Diagnosis and Intervention for Preventive Care and Critical Cases
Read more

IDEXX Innovative Diagnostic and Software Solutions Provide Workflow Efficiency and Faster, More Confident Clinical Decisions
Read more

IDEXX Enables Improved Cancer Diagnosis and Personalized Care through Expanded Oncology Offering
Read more

IDEXX Acquires ezyVet
Read more

IDEXX and the Tuskegee University College of Veterinary Medicine Announce Landmark Initiative
Read more

OPTI Medical Systems Receives CE Mark for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19
Read more

IDEXX Provides U.S. Companion Animal Market Trends Update
Read more

View the U.S. Companion Animal Market Trends Snapshot

IDEXX Newsroom

Events and presentations

IDEXX Investor Day 2023
Thursday, August 10, 2023, 8:00 am EDT
View presentation

IDEXX Second Quarter 2023 Earnings Conference Call
Tuesday, August 1, 2023, 8:30 am EDT

Stifel Jaws & Paws Conference
Wednesday, May 31, 2023, 1:15 pm EDT

IDEXX First Quarter 2023 Earnings Conference Call
Tuesday, May 2, 2023 8:30 AM EDT

44th Annual Raymond James Institutional Investors Conference
March 6, 2023, 10:25 am EST
View presentation

IDEXX Fourth Quarter 2022 Earnings Conference Call
Monday, February 6, 2023, 8:30 am EST

IDEXX Third Quarter 2022 Earning Conference Call
November 1, 2022, 8:30 am EDT

IDEXX Second Quarter 2022 Earnings Conference Call
August 2, 2022, 8:30 am EDT

View all events and presentations

*Pricing delayed by 20 minutes